Select Page
New Drugs Will Lower Cholesterol While Raising Costs

New Drugs Will Lower Cholesterol While Raising Costs

A new class of injectable medications will soon be available for use in treating high cholesterol. These drugs are called PCSK9 inhibitors, and they’re currently still in development by a variety of pharmaceutical companies. Approvals are expected midyear. While news...
A Glimpse into the Future of Pharmacy Benefits

A Glimpse into the Future of Pharmacy Benefits

It’s no secret that the costs for prescription drugs are skyrocketing. What’s interesting (and disheartening) is that costs are increasing rapidly whether we’re talking about new drugs being introduced into the marketplace (think $85,000-100,000 to treat hepatitis C)...

The Hep C Drug Field Narrows

Today Bristol-Myers Squibb announced their decision to pull out of the hepatitis C drug race. We were expecting to see a combination therapy from Bristol-Myers in December or early 2015. Gilead, the manufacturer of Sovaldi and another Sovaldi combination therapy...